Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Saunders

Showing results (191-200 of 276) with videos related to

Pageof 28
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
A novel synthesis of 2-arylpyrrolo[1,2-a]pyrimid-7-ones and their structure-activity relationships as potent GnRH receptor antagonistsYun-Fei Zhu, Keith Wilcoxen, John Saunders, et al.
International Journal of STD & AIDS|August 22, 2025
Thinking beyond the tablet: Acceptability of different HIV-PrEP modalities among GBMSM and gender-diverse individuals having sex with men in the UKDana Ogaz, Natasha Ratna, Hridhya Vijayan, et al.
BMJ Public Health|March 11, 2026
Prevalence and factors associated with use of prophylaxis for HIV and sexually transmitted infections among sexual health service attendees in England: findings from a cross-sectional observational studyJames Bell, Manik Kohli, Caisey Pulford, et al.
BMJ Open|March 5, 2025
Impact of hospital-based early detection on management in chronic kidney disease: the CKD Stewardship study (CKD-S) - protocol for a prospective, multicentre, observational cohort studyLucinda Alix Wynter, Brendan Smyth, John Saunders, et al.
The New England Journal of Medicine|December 21, 2007
TP53 mutations and survival in squamous-cell carcinoma of the head and neckM Luana Poeta, Judith Manola, Meredith A Goldwasser, et al.
International Journal of STD & AIDS|June 12, 2025
British Association for Sexual Health and HIV (BASHH) UK national guideline for the use of doxycycline post-exposure prophylaxis (DoxyPEP) for the prevention of syphilis, 2025John Saunders, Joseph Deering, Claire Dewsnap, et al.
Journal of Medicinal Chemistry|March 4, 2005
Rational design, synthesis, and structure-activity relationships of aryltriazoles as novel corticotropin-releasing factor-1 receptor antagonistsRichard F Lowe, Jodene Nelson, Trunghau N Dang, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|June 17, 2016
Combinations of physical activity, sedentary behaviour and sleep: relationships with health indicators in school-aged children and youthTravis John Saunders, Casey Ellen Gray, Veronica Joan Poitras, et al.
Sexually Transmitted Infections|July 15, 2025
'It does fill me with a bit of unease': a qualitative study of the acceptability, facilitators and barriers to reducing the frequency of screening for asymptomatic sexually transmitted infections among gay, bisexual and other men who have sex with menWilliam Berners-Lee, Melissa Cabecinha, James Bell, et al.
Journal of Medicinal Chemistry|May 16, 2003
Identification of 1-arylmethyl-3- (2-aminoethyl)-5-aryluracil as novel gonadotropin-releasing hormone receptor antagonistsYun-Fei Zhu, Timothy D Gross, Zhiqiang Guo, et al.
Pageof 28

Showing results (191-200 of 276) with videos related to

Sort By:
Pageof 28
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
A novel synthesis of 2-arylpyrrolo[1,2-a]pyrimid-7-ones and their structure-activity relationships as potent GnRH receptor antagonistsYun-Fei Zhu, Keith Wilcoxen, John Saunders, et al.
International Journal of STD & AIDS|August 22, 2025
Thinking beyond the tablet: Acceptability of different HIV-PrEP modalities among GBMSM and gender-diverse individuals having sex with men in the UKDana Ogaz, Natasha Ratna, Hridhya Vijayan, et al.
BMJ Public Health|March 11, 2026
Prevalence and factors associated with use of prophylaxis for HIV and sexually transmitted infections among sexual health service attendees in England: findings from a cross-sectional observational studyJames Bell, Manik Kohli, Caisey Pulford, et al.
BMJ Open|March 5, 2025
Impact of hospital-based early detection on management in chronic kidney disease: the CKD Stewardship study (CKD-S) - protocol for a prospective, multicentre, observational cohort studyLucinda Alix Wynter, Brendan Smyth, John Saunders, et al.
The New England Journal of Medicine|December 21, 2007
TP53 mutations and survival in squamous-cell carcinoma of the head and neckM Luana Poeta, Judith Manola, Meredith A Goldwasser, et al.
International Journal of STD & AIDS|June 12, 2025
British Association for Sexual Health and HIV (BASHH) UK national guideline for the use of doxycycline post-exposure prophylaxis (DoxyPEP) for the prevention of syphilis, 2025John Saunders, Joseph Deering, Claire Dewsnap, et al.
Journal of Medicinal Chemistry|March 4, 2005
Rational design, synthesis, and structure-activity relationships of aryltriazoles as novel corticotropin-releasing factor-1 receptor antagonistsRichard F Lowe, Jodene Nelson, Trunghau N Dang, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|June 17, 2016
Combinations of physical activity, sedentary behaviour and sleep: relationships with health indicators in school-aged children and youthTravis John Saunders, Casey Ellen Gray, Veronica Joan Poitras, et al.
Sexually Transmitted Infections|July 15, 2025
'It does fill me with a bit of unease': a qualitative study of the acceptability, facilitators and barriers to reducing the frequency of screening for asymptomatic sexually transmitted infections among gay, bisexual and other men who have sex with menWilliam Berners-Lee, Melissa Cabecinha, James Bell, et al.
Journal of Medicinal Chemistry|May 16, 2003
Identification of 1-arylmethyl-3- (2-aminoethyl)-5-aryluracil as novel gonadotropin-releasing hormone receptor antagonistsYun-Fei Zhu, Timothy D Gross, Zhiqiang Guo, et al.
Pageof 28